Title: Anti-Human CD26/DPP4 Antibody (BT 5/9): A Versatile Tool for Biotech Research
Introduction:
The Anti-Human CD26/DPP4 Antibody (BT 5/9) is a highly specific and reliable tool for biotech research. This antibody targets the CD26/DPP4 protein, which plays a crucial role in various biological processes. With its superior quality and versatility, this antibody is a must-have for any biotech laboratory.
Biological Function:
CD26/DPP4 is a multifunctional transmembrane protein that is involved in various physiological processes, including immune response, cell adhesion, and glucose metabolism. It acts as a receptor and enzyme, mediating signaling pathways that regulate cell growth, differentiation, and migration. The Anti-Human CD26/DPP4 Antibody (BT 5/9) specifically binds to the extracellular domain of CD26/DPP4, inhibiting its enzymatic activity and modulating its signaling functions.
Main Applications:
This antibody has a wide range of applications in biotech research. It is commonly used in studies related to immunology, cancer, and metabolic disorders. In immunology, the Anti-Human CD26/DPP4 Antibody (BT 5/9) is used to investigate the role of CD26/DPP4 in immune cell activation, differentiation, and migration. In cancer research, it is utilized to study the role of CD26/DPP4 in tumor growth, angiogenesis, and metastasis. Additionally, this antibody is also valuable in metabolic disorder research, as CD26/DPP4 is involved in glucose homeostasis and insulin signaling.
Experimental Use Cases:
The Anti-Human CD26/DPP4 Antibody (BT 5/9) has been extensively validated for various experimental techniques, including Western blot, immunohistochemistry, and flow cytometry. In Western blot analysis, it shows specific and strong bands at the expected molecular weight of CD26/DPP4. In immunohistochemistry, it produces clear and consistent staining of CD26/DPP4 in tissue sections. In flow cytometry, this antibody can detect CD26/DPP4 expression on various cell types, providing valuable insights into its role in different cell populations.
This antibody is a potent tool for researchers studying CD26/DPP4 in immunology, cancer, and metabolic disorders. Its specificity and versatility make it an ideal choice for techniques such as Western blot, immunohistochemistry, and flow cytometry. With the Anti-Human CD26/DPP4 Antibody (BT 5/9), scientists can gain a deeper understanding of the biological functions of CD26/DPP4 and its potential as a therapeutic target.
Conclusion:
In summary, the Anti-Human CD26/DPP4 Antibody (BT 5/9) is a highly specific and reliable tool for biotech research. Its ability to inhibit CD26/DPP4 enzymatic activity and modulate its signaling functions makes it a valuable asset in various studies. With its extensive validation and wide range of applications, this antibody is an essential addition to any biotech laboratory. Purchase now and advance your research with the Anti-Human CD26/DPP4 Antibody (BT 5/9).
There are no reviews yet.